Clonal expansions occur in the persistent HIV reservoir as shown by the duplication of proviral integration sites. However, the source of the proliferation of HIV-infected cells remains unclear. Here, we analyze the TCR repertoire of single HIV-infected cells harboring...

During these times of uncertainty and growing change, CanCURE is continually committed and focused on studying HIV persistence during antiretroviral therapy and developing strategies towards a sustainable HIV remission. With monthly meetings joining together all CanCUR...

On May 1st and 2nd 2020, the 29th Annual conference of the Canadian Association for HIV Research (CAHR) was held. Although unable to attend the conference onsite, many CanCURE members were present to give their oral talks and posters virtually! Please se...

CanCURE members are pleased to announce the below recently awarded scholarships:

From Dr. Jean-Pierre Routy's lab, postdoctoral fellow Dr. Stéphane Isnard won both a Fonds de recherche du Québec - Santé (FRQS) scholarship as well as a CIHR Canadian HIV Trials Network’s...

On the 10-13th of December 2019, the 9th edition of the HIV Persistence during Therapy - Reservoirs and Eradication Strategies workshop took place in Miami, Florida. CanCURE members were present to attend and discuss their latest research as well as current matters on...

The introduction of combined antiretroviral therapy (cART) in the treatment of HIV infection in the 1990s has dramatically changed the course of this disease. However, the persistence of viral DNA within host cells is one of the main obstacles to eradicate the virus, a...

CanCURE would like to express its commitment to the fight against the HIV pandemic on this World AIDS Day 2019. The Team's research program aimed at developing strategies towards an HIV Cure is part of Canada's contribution to the global AIDS response....

CanCURE's Lead Investigator Éric Cohen and his team at the Montreal Clinical Research Institute have identified a way to thwart HIV infection at its very early stages

MONTREAL, November 26, 2019 - 1.7  million. That’s how many people are infected with the human imm...

The fifth Annual Meeting of the Canadian HIV Cure Enterprise (CanCURE) was held at the IRCM on November 7th and 8th 2019. This research consortium focused on HIV Cure is led by Dr. Éric A. Cohen, Research Professor at the IRCM and Director of the Human Retrovirology re...

On November 8th join us for a CanCURE Public Event!!
Taking place at the IRCM from 2:30-4:30 PM - Learn about the challenges and opportunities in HIV Cure research today. To register please contact anita.del.corpo@ircm.qc.ca

On the 21-24th of July 2019, The International Aids Society (IAS) will be holding its 10th IAS Conference on HIV Science in Mexico City, Mexico. CanCURE members will be present to attend and discuss their latest research as well as current matters on HIV. Principle inv...

The CanCURE team is excited to announce CanCURE's renewal for an additional 5 years spanning from 2019 to 2024. The CanCURE initiative brings together 19 collaborators and aims to address key gaps limiting the ability to cure HIV — by harnessing the synergy between bas...

CanCURE members will be attending the CROI Conference: Conference on Retroviruses and Opportunistic Infections on March 4-7th, 2019 in Seattle, Washington. Students and Trainees from the laboratories of CanCURE Investigators Jean-Pierre Routy, Zabrina Brumme, Petronela...

On behalf of the entire CanCURE team we would like to wish you and yours good health, happiness, and success in the coming year and always. Happy New Year!

Research done by CanCURE members was recently publish in prestigious journals such as Retrovirology and PNAS. In order to reach out to the public, lay summaries have been prepared with researchers and community members. Within CanCURE, we hope these postings will incre...